Cite
SARS-CoV-2-related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point-of-care ultrasound.
MLA
Galassi, Andrea, et al. “SARS-CoV-2-Related ARDS in a Maintenance Hemodialysis Patient: Case Report on Tailored Approach by Daily Hemodialysis, Noninvasive Ventilation, Tocilizumab, Anxiolytics, and Point-of-Care Ultrasound.” Clinical Case Reports, vol. 9, no. 2, Dec. 2020, pp. 694–703. EBSCOhost, https://doi.org/10.1002/ccr3.3623.
APA
Galassi, A., Casanova, F., Gazzola, L., Rinaldo, R., Ceresa, M., Restelli, E., Giorgini, A., Birocchi, S., Giovenzana, M., Zoni, U., Valli, F., Massironi, L., Belletti, S., Magagnoli, L., Stucchi, A., Ippolito, M., Carugo, S., Parazzini, E., & Cozzolino, M. (2020). SARS-CoV-2-related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point-of-care ultrasound. Clinical Case Reports, 9(2), 694–703. https://doi.org/10.1002/ccr3.3623
Chicago
Galassi, Andrea, Francesca Casanova, Lidia Gazzola, Rocco Rinaldo, Marco Ceresa, Elena Restelli, Alessia Giorgini, et al. 2020. “SARS-CoV-2-Related ARDS in a Maintenance Hemodialysis Patient: Case Report on Tailored Approach by Daily Hemodialysis, Noninvasive Ventilation, Tocilizumab, Anxiolytics, and Point-of-Care Ultrasound.” Clinical Case Reports 9 (2): 694–703. doi:10.1002/ccr3.3623.